Identifier to cite or link to this item:
https://hdl.handle.net/20.500.13003/27770 Adipokines and satiety hormones and incidence of Alzheimer’s disease and dementia in older adults: a nested case-control study
Loading...
Identifiers
ISSN: 2509-2723
WOS ID: 001808440000001
Scopus EID: 2-s2.0-105043799840
PMID: 42387181
Embase PUI: L2047081022
Authors
Hernáez, Álvaro
Hernando-Redondo, Javier
Chillarón, Juan J.
Ros, Emilio
Martínez-González, Miguel Ángel
Corella, Dolores
Salas-Salvadó, Jordi
Estruch, Ramon
Timiraos, Juan
Hernández, Marta H.
Advisors
Share
Date of defense
Publication date
2026-07-02
Document type
research article
Citation
Hernáez Á, Hernando-Redondo J, Chillarón JJ, Ros E, Martínez-González MÁ, Corella D, et al. Adipokines and satiety hormones and incidence of Alzheimer’s disease and dementia in older adults: a nested case-control study. GeroScience. 2026 Jul 2.
Volume Title
Abstract
Abstract Obesity is known to have an intricate relationship with the development of Alzheimer’s disease and dementia (mid-life obesity increases risk, whereas late-life adiposity may also have an effect). In this context, adipokines and satiety signals are suggested to play a role in late life, but their association with the incidence of these outcomes remains unclear. Our study aimed to assess whether five selected plasma adipokines and satiety hormones (leptin, ghrelin, resistin, adipsin, and fibroblast growth factor-21) were associated with incident Alzheimer’s disease and dementia in older adults at high cardiovascular risk in a nested case-control study within the PREDIMED trial (90 dementia cases [73 of which were Alzheimer’s disease], 156 controls). Participants were at high cardiovascular disease risk but free from dementia at baseline. Associations with biomarkers were assessed using multivariable conditional logistic regression. Higher resistin levels were associated with higher incidence of Alzheimer’s disease in the multivariable-adjusted model (per one SD increase: OR 1.56, 95% CI 1.02 to 2.38); additional adjustment for body mass index slightly attenuated the association (OR 1.52, 95% CI 0.99 to 2.34). Our findings should be replicated in larger prospective studies but suggest that, despite the complex association between anthropometric measures and the incidence of dementia, high levels of resistin were tentatively associated with greater odds of incident Alzheimer’s disease in older adults at high cardiovascular risk.
Description
Publisher version
Research data
Referenced by
It is version of
It is versioned by
Keywords
Complement factor D Dementia, Alzheimer’s disease Fibroblast growth factor-21 Resistin







